Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.97% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBP
3376
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $54.2K | ﹤0.01% |
63,800
| – | – |
|
3377
Offerpad Solutions
OPAD
$21.8M
| $54K | ﹤0.01% |
1,895
-30
| -2% | -$1.07K |
|
|
TBHC
3378
DELISTED
The Brand House Collective
TBHC
| $53.9K | ﹤0.01% |
33,285
-17,315
| -34% | -$31.3K |
|
|
WPRT
3379
Westport Fuel Systems
WPRT
$32.7M
| $53.8K | ﹤0.01% |
15,023
+841
| +6% | +$3.53K |
|
3380
Lulu's Fashion Lounge
LVLU
$44.3M
| $53K | ﹤0.01% |
3,127
+67
| +2% | +$1.37K |
|
3381
Presidio Property Trust
SQFT
$2.09M
| $52.8K | ﹤0.01% |
6,595
-240
| -4% | -$1.67K |
|
3382
Oxbridge Re Holdings
OXBR
$10.5M
| $52.3K | ﹤0.01% |
+12,700
| New | +$39.8K |
|
3383
MIRA Pharmaceuticals
MIRA
$31.5M
| $52.2K | ﹤0.01% |
+45,772
| New | +$59.8K |
|
3384
Atlantic American Corp
AAME
$29M
| $51.7K | ﹤0.01% |
33,600
-1,200
| -3% | -$1.92K |
|
|
AIM
3385
AIM ImmunoTech
AIM
$7.17M
| $51.6K | ﹤0.01% |
2,607
+172
| +7% | +$4.01K |
|
|
ZAPP
3386
DELISTED
Zapp Electric Vehicles
ZAPP
| $51.5K | ﹤0.01% |
+40,556
| New | +$82.4K |
|
3387
SemiLEDS
LEDS
$17.6M
| $51.2K | ﹤0.01% |
39,716
+27,016
| +213% | +$34.3K |
|
3388
Tenon Medical
TNON
$2.96M
| $50.8K | ﹤0.01% |
+771
| New | +$79.1K |
|
3389
Ascent Solar Technologies
ASTI
$32.7M
| $50.7K | ﹤0.01% |
+15,500
| New | +$42.4K |
|
3390
SuperCom
SPCB
$70.3M
| $49.6K | ﹤0.01% |
+10,300
| New | +$36.6K |
|
3391
GD Culture Group
GDC
$7.78M
| $49.5K | ﹤0.01% |
105
-204
| -66% | -$115K |
|
|
FLZH
3392
Flash Sports & Media Holdings
FLZH
$74.9M
| $49.4K | ﹤0.01% |
2,092
+16
| +0.8% | +$568 |
|
|
AXG
3393
Solowin Holdings
AXG
$533M
| $49.2K | ﹤0.01% |
29,800
-16,100
| -35% | -$39.5K |
|
|
SRG
3394
Seritage Growth Properties
SRG
$128M
| $48.6K | ﹤0.01% |
+11,800
| New | +$50.8K |
|
3395
Sagimet Biosciences
SGMT
$577M
| $48.6K | ﹤0.01% |
10,800
-220,300
| -95% | -$1.12M |
|
|
ADIL
3396
Adial Pharmaceuticals
ADIL
$9.61M
| $48.1K | ﹤0.01% |
+1,905
| New | +$49.6K |
|
3397
Performance Shipping
PSHG
$21.5M
| $47.4K | ﹤0.01% |
25,500
-76,200
| -75% | -$143K |
|
|
PW
3398
Power REIT
PW
$2.93M
| $47.2K | ﹤0.01% |
3,550
-2,640
| -43% | -$32.9K |
|
|
DGXX
3399
Digi Power X Inc
DGXX
$407M
| $47K | ﹤0.01% |
31,300
+18,300
| +141% | +$29.9K |
|
|
CHRN
3400
ChronoScale Holdings
CHRN
$2.99B
| $46.3K | ﹤0.01% |
5,061
+87
| +2% | +$1.07K |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.